These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 414047)

  • 41. Multiple myeloma and related plasma cell dyscrasias.
    Osserman EF; Merlini G; Butler VP
    JAMA; 1987 Nov; 258(20):2930-7. PubMed ID: 3118064
    [No Abstract]   [Full Text] [Related]  

  • 42. [Blood coagulation disorders in paraproteinemic hemoblastoses].
    Deutsch E; Lechner K
    Wien Klin Wochenschr; 1972 Apr; 84(16):253-6. PubMed ID: 4623270
    [No Abstract]   [Full Text] [Related]  

  • 43. [The monitoring of protein-volemic indices during plasmapheresis in patients with paraproteinemic hemoblastoses].
    Kalinin NN; Movshev BE; Petrov MM; Petrova VI; Droshneva VA; Varlamova SV; Khoroshko ND; Zhuravlev VS; Loginov SP
    Ter Arkh; 1996; 68(7):62-5. PubMed ID: 8928075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [On the clinical aspects of paraproteinemias].
    Brittinger G; König E
    Schweiz Med Wochenschr; 1965 Nov; 95(46):1584-8. PubMed ID: 4957596
    [No Abstract]   [Full Text] [Related]  

  • 45. [Monoclonal gammopathy and osteolytic lesions as the initial manifestation of a metastatic hypernephroma].
    Castillo Jimeno JM; Illarramendi Mañas JJ; Ruiz Rubio JL; Santiago González A; Sebastián Borruel JL
    Arch Esp Urol; 1991 Nov; 44(9):1110-2. PubMed ID: 1807217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of paraproteinemic hemoblastoses].
    Fereberger W
    Acta Med Austriaca; 1982; 9(4):151-7. PubMed ID: 6814158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Atypical paraproteinemic hemoblastoses (author's transl)].
    Rentsch I; Gärtner U; Stocker W
    MMW Munch Med Wochenschr; 1978 Nov; 120(47):1567-70. PubMed ID: 102955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [On the diagnosis of paraproteinemias].
    Aly FW
    Med Welt; 1968 Jan; 1():19-23. PubMed ID: 4973896
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immunochemical analysis of 1400 paraproteinemic sera from a patient population].
    Tichý M; Hrncír Z; Matĕja F; Mracek J
    Vnitr Lek; 1988 Apr; 34(4):313-21. PubMed ID: 3134762
    [No Abstract]   [Full Text] [Related]  

  • 50. Plasma cell dyscrasias.
    Barlogie B; Alexanian R; Jagannath S
    JAMA; 1992 Nov; 268(20):2946-51. PubMed ID: 1433713
    [No Abstract]   [Full Text] [Related]  

  • 51. [Significance of immunoelectrophoresis for the clinical diagnosis of paraproteinemias].
    Engel R
    Verh Dtsch Ges Inn Med; 1965; 71():480-3. PubMed ID: 4961496
    [No Abstract]   [Full Text] [Related]  

  • 52. Significance of M-components in plasma cell myeloma and related disorders.
    Kano T
    Tohoku J Exp Med; 1970 Dec; 102(4):341-67. PubMed ID: 4101555
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunofluorescence as an aid in the detection and classification of paraproteinaemia.
    Hijmans W; Schuit HR; van Nieuwkoop JA; van Camp B
    Ric Clin Lab; 1980; 10(1):17-21. PubMed ID: 6162186
    [No Abstract]   [Full Text] [Related]  

  • 54. Blood stem cell transplantation to treat cystic lung light chain deposition disease.
    Borgne AL; Prévot G; Rouquette I; Huynh A; Têtu L; Projetti F; Carreiro M; Borie R; Jaccard A; Recher C; Didier A
    Eur Respir J; 2015 Oct; 46(4):1199-202. PubMed ID: 26160867
    [No Abstract]   [Full Text] [Related]  

  • 55. Multiple myeloma. Clinical practice guidelines in oncology.
    Anderson KC; Alsina M; Bensinger W; Biermann JS; Chanan-Khan A; Comenzo RL; De Castro CM; Djulbegovic B; Farag S; Huff CA; Meredith R; Schriber J; Shrieve D; Singhal S; Smith MR; Stockerl-Goldstein K; Vose JM; Weber D; Yahalom J; Yunus F;
    J Natl Compr Canc Netw; 2007 Feb; 5(2):118-47. PubMed ID: 17335683
    [No Abstract]   [Full Text] [Related]  

  • 56. [Plasmacytoma of the ENT region. Diagnosis and therapy].
    Waldfahrer F; Heinritz H; Kraus T; Iro H
    HNO; 1995 Feb; 43(2):111-29. PubMed ID: 7713763
    [No Abstract]   [Full Text] [Related]  

  • 57. [The development of multiple myeloma in chronic diffuse liver diseases with a long course of monoclonal immunoglobulinopathy (a description of 2 cases)].
    Krel' PE; Andreeva NE; Aprosina ZG
    Ter Arkh; 1991; 63(8):130-4. PubMed ID: 1792603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The paraproteinemias. Clinico-biological study of hospital cases].
    Monti G; Cereda UG; Motta M; Borghi A; Barberi G
    Minerva Med; 1980 Oct; 71(39):2803-14. PubMed ID: 6776447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proceedings: Protein analysis in the diagnosis and monitoring of myeloma and macroglobulinaemia.
    Carter PM
    Br J Radiol; 1976 Mar; 49(579):290. PubMed ID: 819078
    [No Abstract]   [Full Text] [Related]  

  • 60. [Laboratory diagnosis of myeloma disease (review of the literature)].
    Lugovskaia SA
    Vrach Delo; 1982 Jan; (1):57-61. PubMed ID: 7041423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.